Not applicableActive Not RecruitingNCT06396611What this trial is testingExercise As Intervention in Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Universidade do Porto 11
Testing effectiveness (Phase 2)Looking for participantsNCT07154264What this trial is testingDZD8586 Combination in CLL/SLL (TAI-SHAN10)Who this might be right forChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Dizal Pharmaceuticals 66
Not applicableStudy completedNCT02080884What this trial is testingAn Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Hoffmann-La Roche 150
Early research (Phase 1)UnknownNCT03840317What this trial is testingSenl_1904A and Senl_1904B Chimeric Antigen Receptor （CAR） T-Cell in the Treatment of r/ r Acute B Lymphocytic LeukemiaWho this might be right forAcute Lymphocytic Leukemia Hebei Senlang Biotechnology Inc., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT01865617What this trial is testingLaboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic LeukemiaWho this might be right forCD19-Positive Neoplastic Cells PresentRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+10 more Fred Hutchinson Cancer Center 204
Not applicableEnded earlyNCT00513318What this trial is testingPilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic MalignanciesWho this might be right forAcute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+4 more University of California, San Francisco 15
Testing effectiveness (Phase 2)UnknownNCT01016990What this trial is testingValproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Auxilio Mutuo Cancer Center 52
Early research (Phase 1)Study completedNCT00313508What this trial is testingDendritic Cell Vaccination During Lymphoid ReconstructionWho this might be right forIntraocular MelanomaMelanoma (Skin) H. Lee Moffitt Cancer Center and Research Institute 18
Early research (Phase 1)Looking for participantsNCT07020533What this trial is testingA Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more City of Hope Medical Center 46
Testing effectiveness (Phase 2)Study completedNCT00899847What this trial is testingPhase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATGWho this might be right forTransplantation, HomologousTransplantation, AutologousMultiple Myeloma+1 more Stanford University 9
Not applicableStudy completedNCT04246840What this trial is testingStudy Through Imaging of Visceral Lymphoid Organs in Patients With SCID Who Have Recieved Bone Marrow AllograftWho this might be right forSevere Combined Immunodeficiency Association Pour l'Aide a la Recherche en Immunologie Pediatrique 18
Testing effectiveness (Phase 2)Study completedNCT00019097What this trial is testingVaccine Therapy in Treating Patients With Multiple MyelomaWho this might be right forStage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01414426What this trial is testingVandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck LesionsWho this might be right forLip and Oral Cavity Squamous Cell CarcinomaOral Cavity Verrucous CarcinomaPrecancerous Condition University of Chicago 20
Testing effectiveness (Phase 2)Study completedNCT00391989What this trial is testingTreatment of Adult Ph+ LAL With BMS-354825Who this might be right forLymphoblastic Leukemia, Acute Gruppo Italiano Malattie EMatologiche dell'Adulto 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07562568What this trial is testingSHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDSWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more The First Affiliated Hospital of Soochow University 160
Testing effectiveness (Phase 2)Study completedNCT01643668What this trial is testingBusulfan/Clofarabine + Allogeneic Stem Cell TransplantationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome Massachusetts General Hospital 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439110What this trial is testingTesting Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT04515238What this trial is testingSequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLLWho this might be right forChronic Lymphoid Leukemia German CLL Study Group 42
Testing effectiveness (Phase 2)Looking for participantsNCT07471789What this trial is testingSafety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).Who this might be right forAcute Myeloblastic LeukaemiaLeukemia, T-Cell Gyala Therapeutics 33
Testing effectiveness (Phase 2)WithdrawnNCT03187691What this trial is testingSafety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic LeukaemiaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia Matinas BioPharma Nanotechnologies, Inc.